Clinical trials
Phase 2 Lupus Nephritis trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Biogen | 2 |
| Novartis Pharmaceuticals | 2 |
| Akebia Therapeutics | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| Autolus Limited | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Kezar Life Sciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Nephritis | 13 |
| Lupus Erythematosus, Systemic | 6 |
| Glomerulonephritis, IGA | 2 |
| Proteinuria | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.